Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Mylan outlines plans for antiretroviral treatment TLE-400

Dec. 2, 2015

Shionogi presents anti-HIV agents

Nov. 27, 2015

Gilead Sciences' Genvoya approved in E.U. for HIV-1 infection

Nov. 24, 2015

NIAID and GSK collaborate on broadly neutralizing antibody strategy for HIV infection

Nov. 23, 2015

FDA approves Genvoya single-tablet regimen for HIV-1

Nov. 6, 2015

ViiV Healthcare and Janssen report results from injectable cabotegravir regimen study

Nov. 5, 2015

Bristol-Myers Squibb reports HIV maturation inhibitors

Oct. 27, 2015

CHMP recommends extension of approval of rilpivirine to adolescents with HIV infection

Oct. 27, 2015

Genvoya noninferior to Stribild in phase III studies in treatment-naive adults with HIV infection

Oct. 23, 2015

Fecal microbiome transplant shows favorable safety profile in HIV-infected subjects

Oct. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...